Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy

Authors Dang Y, Sun X, Xu Y, Mu Y, Zhao M, Zhao J, Zhu Y, Zhang C

Received 9 September 2013

Accepted for publication 3 October 2013

Published 9 January 2014 Volume 2014:10 Pages 37—43

DOI https://doi.org/10.2147/TCRM.S54213

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Yalong Dang,1–3,# Xinfeng Sun,2,# Yongsheng Xu,3,# Yalin Mu,2 Manli Zhao,2 Jing Zhao,2 Yu Zhu,1 Chun Zhang3

1Department of Ophthalmology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 2Department of Ophthalmology, Yellow River Hospital, Henan University of Science and Technology, Sanmenxia, Henan Province, 3Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, People's Republic of China

#These authors contributed equally to this work

Background: The purpose of this study was to evaluate changes in subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy (ICSCR).
Methods: This was a retrospective observational study conducted in 63 participants. The primary outcome measure was subfoveal choroidal thickness at baseline and 3 days, one week, 4 weeks, and 12 weeks after photodynamic therapy. The secondary outcome measure was indocyanine green angiography at baseline and 4 weeks and 12 weeks after photodynamic therapy.
Results: Four weeks after photodynamic therapy, 20 (64.51%) symptomatic eyes showed hypofluorescence corresponding to the area of photodynamic therapy irradiation at the posterior pole. The mean subfoveal choroidal thickness increased significantly from 422±132 µm at baseline to 478±163 µm at day 3 after treatment (P=0.022) and then decreased to 362±113 µm at week 4 (P<0.001) and 339±135 µm at week 12 (P<0.001).
Conclusion: The subfoveal choroid in patients with acute ICSCR is thicker than in the normal population, and in symptomatic eyes is significantly thicker than in fellow eyes. Photodynamic therapy using a one third dose of verteporfin may decrease choroidal vascular hyperpermeability and choroidal thickness in patients with acute ICSCR.

Keywords: idiopathic central serous chorioretinopathy, photodynamic therapy, subfoveal choroidal thickness, indocyanine green angiography, optical coherence tomography, enhanced depth imaging


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway

Dang Y, Mu Y, Wang K, Xu K, Yang J, Zhu Y, Luo B

Drug Design, Development and Therapy 2016, 10:851-859

Published Date: 26 February 2016

Lower cognitive function in patients with age-related macular degeneration: a meta-analysis

Zhou LX, Sun CL, Wei LJ, Gu ZM, Lv L, Dang Y

Clinical Interventions in Aging 2016, 11:215-223

Published Date: 24 February 2016

Diffuse anterior retinoblastoma: current concepts

Yang J, Dang Y, Zhu Y, Zhang C

OncoTargets and Therapy 2015, 8:1815-1821

Published Date: 22 July 2015

The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients

Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y

Therapeutics and Clinical Risk Management 2013, 9:355-360

Published Date: 2 September 2013

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010